Associations of plasma EBV-DNA load with laboratory parameters and HIF-1α and Th17/Treg-related measures in pediatric infectious mononucleosis: a cross-sectional secondary analysis
The relationship between circulating Epstein–Barr virus (EBV) DNA and host-response variation within pediatric infectious mononucleosis (IM) remains incompletely characterized. We examined whether plasma viral load was associated with routine laboratory parameters and HIF-1α and Th17/Treg-related measures in an existing hospitalized cohort. This cross-sectional secondary analysis reused the 40 children with IM from a previously published case-control study; the 37 healthy controls were not reanalyzed. Plasma EBV-DNA was analyzed by Spearman correlation using log₁₀ copies/mL and categorically using a literature-derived threshold of 10⁴ copies/mL (low load, n = 17; high load, n = 23). The updated Table 4 contains 31 listed correlations. An exploratory source linear model assessed viral-load category and Th17 frequency with adjustment for age and body mass index. Bonferroni sensitivity analyses used the 61-test family described in Methods, subject to reconciliation of the test count. Median plasma EBV-DNA was 4.49 log₁₀ copies/mL (interquartile range, 3.65–4.88); no value was below the assay detection limit. In the updated Table 4, nominal positive correlations were reported for ALT ( r = 0.318), AST (0.348), ADA (0.406), CD3⁺ percentage (0.494), CD4⁺ percentage (0.657), CD3⁺/CD4⁺ ratio (0.682), Th17 frequency (0.323), Th17/Treg ratio (0.480), IL-17 A (0.555), HIF-1α (0.360), thrombin time (0.459), and lymphocyte count (0.387), and nominal negative correlations for CD4⁺/CD8⁺ ratio (− 0.620), Treg frequency (-0.458), TGF-β1 (-0.399), and platelet-to-lymphocyte ratio (− 0.501). None had a Bonferroni-adjusted P value below 0.05 when calculated from the displayed rounded P values using a 61-test correction. The updated analysis suggests exploratory relationships between plasma EBV-DNA and selected laboratory measures within a previously studied hospitalized pediatric IM cohort. It does not establish a consistent continuous association with HIF-1α or Th17-related measures. Small sample size, multiplicity, incomplete adjustment, and assay limitations preclude causal or clinical-use conclusions. Independent longitudinal validation is required.
Authors
- Huiping Ni (ORCID: https://orcid.org/0009-0003-7895-5907)
- Jiaxin Qin
- Mei Wang (ORCID: https://orcid.org/0000-0002-9319-7556)
- 黄莉
- Zheng Guo (ORCID: https://orcid.org/0000-0002-7082-5900)
- Yu Dong (ORCID: https://orcid.org/0000-0001-8318-5001)
- Pengli Yang
- Gaofeng Pang
Institutions
- Soochow University (CN)
- The First People's Hospital of Changzhou (CN)
- Changzhou Third People's Hospital (CN)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1186/s12879-026-14790-6
- Primary Topic
- Viral-associated cancers and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00